Growth normalizes, structural drivers intact
DanaShift's first quarterly outlook on animal health and pet care, covering full-year 2025 results, the Q1 2026 transaction landscape, and the structural shifts shaping where capital and category leadership are headed next.The headline: growth is normalizing rather than weakening, with outperformance concentrating in diagnostics, integrated platforms, long-acting therapeutics, and workflow-linked recurring revenue. The U.S. pet industry reached $158B in 2025 (+3.7% YoY), and global pet care is projected to hit $289B in 2026 with a 7% CAGR through 2034.Inside: a 38-page review of public company performance, more than 100 select transactions across the quarter, and DanaShift's perspective on where the next cycle of care delivery and consolidation is headed.